blog navigation

blog posts

  • Drugs with multiple targets show promise against myotonic dystrophy type 1

    Graduate students, from left, Long Luu and Lien Nguyen, with U. of I. chemistry professor Steven Zimmerman, developed drug compounds that target three pathways associated with myotonic dystrophy type 1.

    Photo by L. Brian Stauffer

    Images

blog posts

  • Editor’s notes:

    To reach Steven Zimmerman, call 217-333-6655; email sczimmer@illinois.edu.

    The paper “Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1” is available online or from the U. of I. News Bureau.